Gene Therapy For Children Approved In Europe
In a global first, gene therapy that could prove life-saving for children has been recommended for approval in Europe. The pioneering technology to fix faulty genes has been developed by Italian scientists and GlaxoSmithKline FOX News reports: The European Medicines Agency (EMA) said on Friday it had endorsed the therapy, called Strimvelis, for a tiny number of children with ADA Severe Combined Immune Deficiency (ADA-SCID) for whom no matching bone marrow donor is available.